C2Sense, Inc.

C2Sense's Chief Technology Officer, Robert Deans, Ph.D., is excited to attend ADLM and discuss our latest algorithmic advancements. To schedule a meeting with Dr. Deans and discuss how C2Sense can enhance your immunoassay performance by eliminating false positives and increasing sensitivity, please contact us at contact@c2sense.com. #ADLM #LFA #immunoassay #assay #assayperformance #assaysensitivity

C2Sense Appoints Former Chief Medical Officer of Walgreens, Dr. Kevin Ban, as Strategic Advisor to its Board of Directors “It is a pleasure to welcome Dr. Ban, with his deep experience and expertise in clinical medicine, international health, healthcare technology and population health management as an advisor to C2Sense’s Board of Directors,” said Jason Cox, Ph.D., CEO of C2Sense. “We look forward to his involvement, strategic insights and guidance as we continue the progress of our Halo® product suite.” For the full press release, visit https://lnkd.in/e8Pbk4zU For more about Halo, visit www.haloreader.com For more about Sick Health with Kevin Ban, MD, visit www.sickhealthshow.com

C2Sense welcomes Dr. Michael Mina, MD, Ph.D., Chief Scientific Officer of eMed Digital Healthcare to its Board of Directors. “We are excited to welcome Dr. Mina, an accomplished industry leader with extensive expertise in infectious diseases, molecular diagnostics and public health to C2Sense’s Board of Directors,” said Jason Cox, Ph.D., CEO of C2Sense. “Dr. Mina will provide strategic and scientific insights across many aspects of our business, including product development and commercialization, as we advance our Halo suite of customizable readers and algorithms.” To read the full release, please visit https://lnkd.in/eZetp3XS

Expanding the reach of our Halo reader into molecular testing! Combining isothermal molecular amplification (LAMP) with the simplicity of a lateral flow readout mechanism (europium or quantum dot based) yields sub-femtomole sensitivities in a model system without adding cost or complexity. Visit www.haloreader.com for more. #LFA #RapidTest #Moleculartest #LAMP #molecularamplification #assay #diagnostics #assaymanufacturer

C2Sense® and Princeton BioMeditech Receive Second Award from NIH RADx® Tech High Performance Program for Digitally Connected, At-Home Diagnostic Reader and Multiplex COVID-19/Flu A&B Rapid Test WATERTOWN, Mass. and MONMOUTH JUNCTION, N.J., April 9, 2024 /PRNewswire/ -- C2Sense, Inc., experts in advanced optical sensing platforms and Princeton BioMeditech Corporation (PBM), a world leader in rapid, point-of-care (POC) diagnostics, announced today that they have secured a second National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech High Performance award. The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture. "After rigorous testing and intensive data collection, Halo®, used in conjunction with the PBM multiplex rapid test, continues to demonstrate outstanding sensitivity and reliability," said Jason Cox, Ph.D., CEO at C2Sense. "Powered by our latest algorithm release, the price vs. performance of our Halo reader is unparalleled." Testing was conducted by the Atlanta Center for Microsystems-Engineered Point-of-Care Technologies (ACME POCT) on behalf of RADx using SARS-CoV-2 (Omicron variant) and Flu A&B viral samples. Visit https://lnkd.in/eYz-wFd6 for more! #FluB # FluA #COVID19 #RADx #RADxTech #NIH #Flu #LFA #Immunoassay #RapidTest #DigitalDiagnostics #AtHomeDiagnostics #testing #digitaltesting #multiplex